The combination of potent HbA1c reduction, minimal hypoglycemia risk, and cardiovascular benefit makes these agents the preferred glucose-lowering option for most patients with type 2 diabetes
Switching from semaglutide to tirzepatide provides receptor novelty through GIP receptor activation while maintaining continuous appetite suppression
GLP-1: Key to Blood Glucose Homeostasis GLP-1 is part of a group of metabolic hormones called incretin hormones that help decrease blood glucose levels
In conclusion, the modifiable risk factors obesity, diabetes, and hypertension increase the risk of COVID-19related mortality in young and middle-aged patients to the level of risk observed in advanced age
Comprehensive review on alzheimers disease: Causes and treatment
Questionable Claims Made by Sellers TGA Approval Misrepresentation : The product claims to be TGA approved, but there is no publicly available listing of it with the Therapeutic Goods Administration of Australia